Engitix

Engitix is a biotech company in London, United Kingdom, founded in 2016. It has raised $54.0M across 1 round, most recently a $54.0M Series A in 2022 (est.).

The ECM company

Headquarters
London, England
Founded
2016
Business Model
B2B
Total Funding
$54.0M
Last Round
$54.0M Series AJan 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Engitix uses tissue- and disease-specific human extracellular matrix scaffolds to model and study mechanisms driving disease biology. Its discovery-stage portfolio targets disease-specific matrix changes to improve outcomes for patients with fibrosis, inflammation, and solid tumours. It seeks collaborations with pharmaceutical and biotechnology companies to expand its platform into additional therapeutic areas.

Summary

It has raised $54.0M in total across 1 round, most recently a $54.0M Series A round in 2022 (est.).

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries A2022 (est.)
$54.0M

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Engitix on Indexed.vc
<a href="https://indexed.vc/companies/engitix"><img src="https://indexed.vc/api/badge/company/engitix" alt="Engitix on Indexed.vc" width="260" height="76" /></a>